Skip to content

Study of two different doses of gabapentin on post operative pain relief and morphine requirement after breast surgery

Study of two different doses of pre-emptive gabapentin on post operative pain relief and morphine requirement after mastectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/018962
Enrollment
70
Registered
2019-05-06
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 4- Measurement and Monitoring

Interventions

Intervention1: Oral Medication: From administration of drug to upto 24 hours of surgery Control Intervention1: Two doses of oral Gabapentin administered as pre-emptive medication: Gabapentin 800mg and

Sponsors

Indira Gandhi Institute of Medical Sciences
Lead Sponsor
Dr Sunny Kumar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Patients willing to participate ASA I and II patients

Exclusion criteria

Exclusion criteria: Patients refusal to participate Patients with known allergy to gabapentin or morphine Patient with daily intake of analgesics or corticosteroids, diabetes or impaired kidney function Patients with an intake of NSAIDs or paracetamol 24 hour prior to operation Patients with an intake of antacids 48 hour prior to operation

Design outcomes

Primary

MeasureTime frame
To compare the effect of two doses of pre-emptive gabapentin on morphine requirement and post operative pain relief in patients undergoing mastectomyTimepoint: From administration of drug to upto 24 hours after surgery

Secondary

MeasureTime frame
To look for any significant adverse effect of gabapentin and morphineTimepoint: From administration of drug to upto 24 hours after surgery

Countries

India

Contacts

Public ContactDr Ajit Gupta

Indira Gandhi Institute of Medical Sciences

ajpta_igims@yahoo.co.uk9473191810

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026